Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Staresinic

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
European Journal of Pharmacology|September 27, 2003
Different effect of antiulcer agents on rat cysteamine-induced duodenal ulcer after sialoadenectomy, but not gastrectomyVlado Bedekovic, Stjepan Mise, Tomislav Anic, et al.
European Journal of Pharmacology|April 21, 2005
Gastric pentadecapeptide BPC 157 effective against serotonin syndrome in ratsAlenka Boban Blagaic, Vladimir Blagaic, Mirela Mirt, et al.
Pharmaceuticals (Basel, Switzerland)|June 27, 2025
Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-SystemPredrag Sikiric, Sven Seiwerth, Anita Skrtic, et al.
Surgery Today|August 1, 2008
Gastric pentadecapeptide BPC 157 as an effective therapy for muscle crush injury in the ratTomislav Novinscak, Luka Brcic, Mario Staresinic, et al.
Pharmaceuticals (Basel, Switzerland)|October 29, 2025
BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide's Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review. <i>Pharmaceuticals</i> 2025, <i>18</i>, 185Predrag Sikiric, Sven Seiwerth, Anita Skrtic, et al.
Pharmaceuticals (Basel, Switzerland)|August 29, 2024
Stable Gastric Pentadecapeptide BPC 157 and Intestinal Anastomoses Therapy in Rats-A ReviewSalem Bajramagic, Marko Sever, Fran Rasic, et al.
Journal of Pharmacological Sciences|November 23, 2006
An experimental model of prolonged esophagitis with sphincter failure in the rat and the therapeutic potential of gastric pentadecapeptide BPC 157Igor Petrovic, Ivan Dobric, Petar Drvis, et al.
Genes|December 24, 2021
Polychromatic Flow Cytometric Analysis of Stromal Vascular Fraction from Lipoaspirate and Microfragmented Counterparts Reveals Sex-Related Immunophenotype DifferencesLucija Zenic, Denis Polancec, Damir Hudetz, et al.
Biomedicines|November 27, 2021
Stable Gastric Pentadecapeptide BPC 157 as a Therapy for the Disable Myotendinous Junctions in RatsMladen Japjec, Katarina Horvat Pavlov, Andreja Petrovic, et al.
Pharmaceuticals (Basel, Switzerland)|June 27, 2025
Acute Compartment Syndrome and Intra-Abdominal Hypertension, Decompression, Current Pharmacotherapy, and Stable Gastric Pentadecapeptide BPC 157 SolutionPredrag Sikiric, Sven Seiwerth, Anita Skrtic, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
European Journal of Pharmacology|September 27, 2003
Different effect of antiulcer agents on rat cysteamine-induced duodenal ulcer after sialoadenectomy, but not gastrectomyVlado Bedekovic, Stjepan Mise, Tomislav Anic, et al.
European Journal of Pharmacology|April 21, 2005
Gastric pentadecapeptide BPC 157 effective against serotonin syndrome in ratsAlenka Boban Blagaic, Vladimir Blagaic, Mirela Mirt, et al.
Pharmaceuticals (Basel, Switzerland)|June 27, 2025
Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-SystemPredrag Sikiric, Sven Seiwerth, Anita Skrtic, et al.
Surgery Today|August 1, 2008
Gastric pentadecapeptide BPC 157 as an effective therapy for muscle crush injury in the ratTomislav Novinscak, Luka Brcic, Mario Staresinic, et al.
Pharmaceuticals (Basel, Switzerland)|October 29, 2025
BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide's Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review. <i>Pharmaceuticals</i> 2025, <i>18</i>, 185Predrag Sikiric, Sven Seiwerth, Anita Skrtic, et al.
Pharmaceuticals (Basel, Switzerland)|August 29, 2024
Stable Gastric Pentadecapeptide BPC 157 and Intestinal Anastomoses Therapy in Rats-A ReviewSalem Bajramagic, Marko Sever, Fran Rasic, et al.
Journal of Pharmacological Sciences|November 23, 2006
An experimental model of prolonged esophagitis with sphincter failure in the rat and the therapeutic potential of gastric pentadecapeptide BPC 157Igor Petrovic, Ivan Dobric, Petar Drvis, et al.
Genes|December 24, 2021
Polychromatic Flow Cytometric Analysis of Stromal Vascular Fraction from Lipoaspirate and Microfragmented Counterparts Reveals Sex-Related Immunophenotype DifferencesLucija Zenic, Denis Polancec, Damir Hudetz, et al.
Biomedicines|November 27, 2021
Stable Gastric Pentadecapeptide BPC 157 as a Therapy for the Disable Myotendinous Junctions in RatsMladen Japjec, Katarina Horvat Pavlov, Andreja Petrovic, et al.
Pharmaceuticals (Basel, Switzerland)|June 27, 2025
Acute Compartment Syndrome and Intra-Abdominal Hypertension, Decompression, Current Pharmacotherapy, and Stable Gastric Pentadecapeptide BPC 157 SolutionPredrag Sikiric, Sven Seiwerth, Anita Skrtic, et al.
Pageof 6